We postulated that obesogenic factors might upregulate hepatic METTL14 and METTL3 to activate the G6pc mRNA m6A/G6pc synthesis/HGP pathway, thereby exacerbating type 2 diabetes progression. The gene discussed is METTL14; the disease is type 2 diabetes mellitus.